novo nordisk lawsuit semaglutide Rybelsus - July 2026 Update Novo Nordisk's lawsuit on unoriginal

AEs: Adverse events, BMI: Body mass index, GI: Gastrointestinal, HbA1c: Glycated haemoglobin, PK/PD: Pharmacokinetics/Pharmacodynamics, RCT: Randomised controlled trial, T2DM: Type 2 diabetes mellitus, wk: Weeks Weight reduction Across all studies, retatrutide produced consistent, dose-dependent reductions in body weight, with the magnitude of effect increasing proportionally to dose and study duration [Table 2]

Purpose-built for physicians Dip in bariatric surgeries shows emerging medical options first approach to weight loss Key takeaways: GLP-1 receptor agonist prescriptions for obesity treatment grew by 132.6% from 2022 to 2023

No more food noise, no more guilt around meals

Use upward, lifting motions to help support a more sculpted appearance

Knowing whats coming is half the battle

It contains semaglutide, the same active ingredient found in Wegovy, but the two medications have different FDA indications, dosing schedules, and clinical trial data